Lymphoma T-cell Cutaneous

• CLINICAL_TRIALS trial_result · 2023-05-11
  Clinical Trial Update: Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma [Phase 2]

  Phase 2 clinical trial update for non-myeloablative allogeneic transplantation using TLI and ATG in patients with cutaneous T-cell lymphoma …

• CLINICAL_TRIALS trial_result · 2022-01-13
  Clinical Trial Update: Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas [Phase 4]

  Phase 4 trial comparing methotrexate to interferon-alfa 2b in patients with primary cutaneous T-cell lymphomas (mycosis fungoides) was termi…

• EMA withdrawal · 2009-02-17
  EMA Application withdrawn: Vorinostat MSD (vorinostat) — Merck Sharp Dohme Limited

  EMA withdrew the application for vorinostat (MSD) by Merck Sharp & Dohme Limited.